Back to Acceleration Radar
SGRYSurgery Partners Inc
Health Care · Hospital/Nursing Management · Small
$15.75−0.94%
As of 23 Oct 2026Mkt cap $1.8B
Stage 13
AVOID
Fundamentals
29.7/75
Technical
11.2/15
Independent
40.9/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +10.9%
- 3M
- +3.8%
- 6M
- +9.8%
- 1Y
- −26.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- —
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 10.7x
- FCF yield
- 9.4%
Quality
- ROIC
- —
- Operating margin
- 11.8%
- FCF margin
- 5.9%
- Current ratio
- 1.9x
Growth
- Revenue growth
- +6.2%Latest FY YoY
- Revenue CAGR
- +10.4%
- EPS CAGR
- —
- FCF CAGR
- +60.5%
Capital
- Share-count trend
- +0.6%3Y annualised
- Net debt
- $3.4B12.3x OCF
Annual trend
- CAGR 2021–2025
- +10.4%
- Latest · 2025
- $3B
- YoY
- +6.2%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-09
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded